SCHEMBL4079401

SCHEMBL4079401

COCCCNC(=S)N(Cc1ccc(F)cc1)Cc1cc2ccc(OC)cc2[nH]c1=O

nearest known ligand 0.82

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.82
NPSR1 Q6W5P4 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
RXFP1 Q9HBX9 1/20 0.53
ALDH1A1 P00352 11/20 0.53
LMNA P02545 5/20 0.53
PKM P14618 2/20 0.53
MAPT P10636 4/20 0.50
KDM4E B2RXH2 8/20 0.49
POLB P06746 1/20 0.49
HSD17B10 Q99714 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
TSHR P16473 2/20 0.48
HPGD P15428 1/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4070747 0.79 MPO (0.57) MPONPSR1MEN1KMT2ARXFP1
SCHEMBL4074148 0.78 ALDH1A1 (0.57) MPONPSR1MEN1KMT2AALDH1A1
SCHEMBL4075241 0.76 ALDH1A1 (0.57) MPONPSR1MEN1KMT2ARXFP1
SCHEMBL4073889 0.74 KDM4E (0.66) MPOMEN1KMT2AALDH1A1LMNA
SCHEMBL4071997 0.73 MPO (0.71) MPONPSR1MEN1KMT2AALDH1A1
SCHEMBL4078096 0.71 ALDH1A1 (0.64) MPONPSR1ALDH1A1LMNAPKM
SCHEMBL4072817 0.69 ALDH1A1 (0.62) MEN1KMT2AALDH1A1LMNAPKM
SCHEMBL13496398 0.69 KDM4E (0.77) NPSR1MEN1KMT2AALDH1A1LMNA
SCHEMBL13496395 0.69 ALDH1A1 (0.73) NPSR1MEN1KMT2ARXFP1ALDH1A1
SCHEMBL4080549 0.69 KDM4E (0.59) MPONPSR1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US claimed
EP-2040711-A2 2-OXO-1,2-DIHYDROQUINOLINE DERIVATIVES, COMPOSITIONS, AND USES THEREOF AS ANTIPROLIFERATIVE AGENTS Amphora Discovery Corporation (US) 2009-04-01 EP disclosed
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US disclosed
WO-2007136592-A2 2-0X0-L,2-DIHYDR0QUIN0LINE DERIVATIVES, COMPOSITIONS, AND USES THEREOF AS ANTIPROLIFERATIVE AGENTS AMPHORA DISCOVERY CORPORATION (US) 2007-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof ABCG2, ATP5ME, ATP5MG MPO 1056/4885NPSR1 4425/4885MEN1 3178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.